Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

A.  van der Veer; V.H.J.  van der Velden; M.E. Willemse; P.G. Hoogeveen; E.F. Petricoin; H.B. Beverloo; G. Escherich; M.A. Horstmann; F.  Pieters; M.L.  van den Boer

doi:10.1038/bcj.2014.5

Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

A. van der Veer, V.H.J. van der Velden, M.E. Willemse, P.G. Hoogeveen, E.F. Petricoin, H.B. Beverloo, G. Escherich, M.A. Horstmann, F. Pieters, M.L. van den Boer^*

^*Corresponding author for this work

GROW - Reproductive and Perinatal Medicine

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	e181
Journal	Blood Cancer Journal
Issue number	2
DOIs	https://doi.org/10.1038/bcj.2014.5
Publication status	Published - 2014

Access to Document

10.1038/bcj.2014.5Licence: CC BY

Cite this

van der Veer, A., van der Velden, V. H. J., Willemse, M. E., Hoogeveen, P. G., Petricoin, E. F., Beverloo, H. B., Escherich, G., Horstmann, M. A., Pieters, F., & van den Boer, M. L. (2014). Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. Blood Cancer Journal, (2), Article e181. https://doi.org/10.1038/bcj.2014.5

@article{327999cbed294c119f8c925070d68a1b,

title = "Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia",

author = "{van der Veer}, A. and {van der Velden}, V.H.J. and M.E. Willemse and P.G. Hoogeveen and E.F. Petricoin and H.B. Beverloo and G. Escherich and M.A. Horstmann and F. Pieters and {van den Boer}, M.L.",

year = "2014",

doi = "10.1038/bcj.2014.5",

language = "English",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

AU - van der Veer, A.

AU - van der Velden, V.H.J.

AU - Willemse, M.E.

AU - Hoogeveen, P.G.

AU - Petricoin, E.F.

AU - Beverloo, H.B.

AU - Escherich, G.

AU - Horstmann, M.A.

AU - Pieters, F.

AU - van den Boer, M.L.

PY - 2014

Y1 - 2014

U2 - 10.1038/bcj.2014.5

DO - 10.1038/bcj.2014.5

M3 - Comment/Letter to the editor

C2 - 24531445

SN - 2044-5385

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 2

M1 - e181

ER -